Category Archives: Research/Treatment

The Food and Drug Administration is entertaining the use of a drug commonly used to treat lung cancer, Opdivo, for use in the treatment of some qualifying mesothelioma patients. The current approval process in motion follows realization in the global medical community that Opdivo has proved to extend the lives of many patients suffering metastatic  Continue Reading »

Mesothelioma researchers and scientists, doctors, and patient advocates are working hard to eradicate mesothelioma as a fatal disease. They work around the world at an intense pace, developing new and more effective treatments, making new discoveries about the disease, and testing better detection methods that may help diagnose mesothelioma in its earlier stages—giving patients a  Continue Reading »

Asbestos use is strictly regulated in the U.S., but the mineral has not been completely banned. Asbestos is still imported into the U.S., mainly from Canada, and many workers are still at risk of exposure during abatement and other construction projects on existing structures. According to a recent National Institute of Environmental Health Sciences (NIEHS)  Continue Reading »

Diagnosing mesothelioma in its early stages offers a number of benefits. Early detection offers better treatment options, better quality of life, and better survival rates. Because mesothelioma is often diagnosed in its later stages, the average survival time for mesothelioma victims (post-diagnosis) is 4 to 30 months. Although the medical landscape offers few incontrovertible studies  Continue Reading »

Malignant mesothelioma(s) are cancerous tumors of the lining of the pleura (lung and chest cavity), caused exclusively by asbestos exposure. Many believed that only long-term exposure to asbestos caused malignant mesothelioma, but it is now known that even short-term and second-hand exposure to asbestos dust can cause this aggressive and debilitating disease. The latency period  Continue Reading »